Key facts
- RxPost’s last known valuation is $1.9M (Jul 2022).
- It has raised $1.9M; the latest was Seed Round ($1.1M) in Jan 2025.
- Notable investors include Fabric VC, Future Communities Capital, 1752vc, Pasadena Private Financial Group, Slauson & Co. — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for RxPost
- ·The full record, as it builds
Funding rounds
No funding rounds for RxPost are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About RxPost
Developer of a digital marketplace and inventory management platform designed to buy and sell excess pharmacy inventory. The company's platform allows pharmacies to sell their unused medications and purchase only what they need, enabling pharmacies, wholesalers and manufacturers to manage surplus inventory efficiently, connect directly with buyers and optimize their supply chain operations.
- Sector
- Business Products and Services (B2B)
- HQ
- Los Angeles, CA, United States
- Founded
- 2021
- Employees
- 6
- Website
- rx-post.com/
- Ownership
- Privately Held (backing)
RxPost doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RxPost shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RxPost in its N-PORT filings yet. We sweep new filings monthly.